Amgen AMGN
NASDAQ AMGN
$407.27 -14.24 (-3.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Amgen (AMGN) Operating Income (2009 - 2026)

Updated

Amgen's Operating Income came in at $3.51 billion for Q2 2026, up 32.3% from $2.66 billion a year earlier and up 31.8% from the prior quarter.

Analysis

Amgen (AMGN) Operating Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Amgen reported Operating Income of $11.43 billion, up 39.5% year-over-year; for FY2025, it was $9.08 billion, up 25.1% from FY2024.

  • Operating Income carries a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
  • Going back by year, Operating Income was $7.26 billion in FY2024 (-8.1%), $7.9 billion in FY2023 (-17.4%), $9.57 billion in FY2022 (+25.2%) and $7.64 billion in FY2021 (-16.4%).
  • The Q2 2026 figure represents the highest quarterly Operating Income in data going back to Q1 2009.
  • Year-over-year, Operating Income has increased for eight consecutive quarters, with growth averaging 42.6% over the last eight quarters.
  • The fastest year-over-year change in Operating Income over five years came in Q2 2022 (growth of 162.8%), and the weakest in Q1 2024 (a decline of 48.4%).
  • Business Quant data shows AMGN's Operating Income at $2.67 billion (Q1 2026), $2.72 billion (Q4 2025) and $2.53 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn 360.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.51 Bn
Mar 31, 2026 2.67 Bn
Dec 31, 2025 2.72 Bn
Sep 30, 2025 2.53 Bn
Jun 30, 2025 2.66 Bn
Mar 31, 2025 1.18 Bn
Dec 31, 2024 2.31 Bn
Sep 30, 2024 2.05 Bn
Jun 30, 2024 1.91 Bn
Mar 31, 2024 991.00 Mn
Dec 31, 2023 1.27 Bn
Sep 30, 2023 2.02 Bn
Jun 30, 2023 2.68 Bn
Mar 31, 2023 1.92 Bn
Dec 31, 2022 2.23 Bn
Sep 30, 2022 2.66 Bn
Jun 30, 2022 2.18 Bn
Mar 31, 2022 2.50 Bn
Dec 31, 2021 2.30 Bn
Sep 30, 2021 2.38 Bn
API Access

Amgen Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=AMGN&period=max&api_key=YOUR_API_KEY